Immune checkpoint inhibitors in cancer patients with COVID-19

Immune checkpoint inhibitors (ICIs) are widely used to treat a variety of cancers and common infectious diseases with high efficacy. During the coronavirus disease 2019 (COVID-19) pandemic, studies suggested that COVID-19 patients may benefit from ICI immunotherapy. However, clinical studies on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yun, Tan, Jiaxiong, Li, Jinzhong, Li, Taoyuan, Li, Jieying, Cao, Yang, Yang, Liu, Lin, Xunge, Li, Minran, Liang, Xujing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329272/
https://www.ncbi.nlm.nih.gov/pubmed/37426624
http://dx.doi.org/10.1515/biol-2022-0641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329272/
https://www.ncbi.nlm.nih.gov/pubmed/37426624
http://dx.doi.org/10.1515/biol-2022-0641

Ejemplares similares